Codiak BioSciences' GAAP loss for 2020 was $91.665 million, up 17.6% from $77.96 million in the previous year. Revenue increased 7.5 times to $2.915 million from $0.388 million a year earlier.
Codiak BioSciences' GAAP loss for 2020 was $91.665 million, up 17.6% from $77.96 million in the previous year. Revenue increased 7.5 times to $2.915 million from $0.388 million a year earlier. 
ir.codiakbio.com
English (US) 